156 related articles for article (PubMed ID: 26315108)
1. Prognostic Role of a Multimarker Analysis of Circulating Tumor Cells in Advanced Gastric and Gastroesophageal Adenocarcinomas.
Kubisch I; de Albuquerque A; Schuppan D; Kaul S; Schaich M; Stölzel U
Oncology; 2015; 89(5):294-303. PubMed ID: 26315108
[TBL] [Abstract][Full Text] [Related]
2. Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study.
de Albuquerque A; Kubisch I; Breier G; Stamminger G; Fersis N; Eichler A; Kaul S; Stölzel U
Oncology; 2012; 82(1):3-10. PubMed ID: 22270149
[TBL] [Abstract][Full Text] [Related]
3. Cryopreservation for delayed circulating tumor cell isolation is a valid strategy for prognostic association of circulating tumor cells in gastroesophageal cancer.
Brungs D; Lynch D; Luk AW; Minaei E; Ranson M; Aghmesheh M; Vine KL; Carolan M; Jaber M; de Souza P; Becker TM
World J Gastroenterol; 2018 Feb; 24(7):810-818. PubMed ID: 29467551
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients.
de Albuquerque A; Kubisch I; Stölzel U; Ernst D; Boese-Landgraf J; Breier G; Stamminger G; Fersis N; Kaul S
J Transl Med; 2012 Nov; 10():222. PubMed ID: 23146106
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of carcinoembryonic antigen-, cytokeratin 19-, or survivin-positive circulating tumor cells in the peripheral blood of esophageal squamous cell carcinoma patients treated with radiotherapy.
Yin XD; Yuan X; Xue JJ; Wang R; Zhang ZR; Tong JD
Dis Esophagus; 2012; 25(8):750-6. PubMed ID: 22394149
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of EpCAM mRNA-positive circulating tumor cells in hepatocellular carcinoma by an optimized negative enrichment and qRT-PCR-based platform.
Guo W; Yang XR; Sun YF; Shen MN; Ma XL; Wu J; Zhang CY; Zhou Y; Xu Y; Hu B; Zhang X; Zhou J; Fan J
Clin Cancer Res; 2014 Sep; 20(18):4794-805. PubMed ID: 25009297
[TBL] [Abstract][Full Text] [Related]
7. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
Schulze K; Gasch C; Staufer K; Nashan B; Lohse AW; Pantel K; Riethdorf S; Wege H
Int J Cancer; 2013 Nov; 133(9):2165-71. PubMed ID: 23616258
[TBL] [Abstract][Full Text] [Related]
8. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
[TBL] [Abstract][Full Text] [Related]
9. Circulating Tumor Cells as an Independent Predictor of Survival in Advanced Gastric Cancer.
Okabe H; Tsunoda S; Hosogi H; Hisamori S; Tanaka E; Tanaka S; Sakai Y
Ann Surg Oncol; 2015 Nov; 22(12):3954-61. PubMed ID: 25777087
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
[TBL] [Abstract][Full Text] [Related]
11. A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer.
Barbazán J; Muinelo-Romay L; Vieito M; Candamio S; Díaz-López A; Cano A; Gómez-Tato A; Casares de Cal Mde L; Abal M; López-López R
Int J Cancer; 2014 Dec; 135(11):2633-43. PubMed ID: 24752533
[TBL] [Abstract][Full Text] [Related]
12. [Value of serum human epithelial growth factor receptor 2 extracellular domain and circulating tumor cells in evaluating therapeutic response in advanced gastric cancer].
Li Y; Peng Z; Zhang X; Gong J; Shen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Nov; 20(11):1293-1299. PubMed ID: 29178102
[TBL] [Abstract][Full Text] [Related]
13. Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study.
Hinz S; Hendricks A; Wittig A; Schafmayer C; Tepel J; Kalthoff H; Becker T; Röder C
BMC Cancer; 2017 Jan; 17(1):53. PubMed ID: 28086834
[TBL] [Abstract][Full Text] [Related]
14. Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients.
de Albuquerque A; Kubisch I; Ernst D; Breier G; Stamminger G; Fersis N; Stölzel U; Boese-Landgraf J; Eichler A; Kaul S
Clin Lab; 2012; 58(5-6):373-84. PubMed ID: 22783565
[TBL] [Abstract][Full Text] [Related]
15. Circulatory Tumor Cells in Esophageal Adenocarcinoma.
Gopalan V; Lam AK
Methods Mol Biol; 2018; 1756():177-186. PubMed ID: 29600370
[TBL] [Abstract][Full Text] [Related]
16. A pilot study assessing the incidence and clinical significance of circulating tumor cells in esophagogastric cancers.
Sclafani F; Smyth E; Cunningham D; Chau I; Turner A; Watkins D
Clin Colorectal Cancer; 2014 Jun; 13(2):94-9. PubMed ID: 24332356
[TBL] [Abstract][Full Text] [Related]
17. Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.
Onstenk W; Kraan J; Mostert B; Timmermans MM; Charehbili A; Smit VT; Kroep JR; Nortier JW; van de Ven S; Heijns JB; Kessels LW; van Laarhoven HW; Bos MM; van de Velde CJ; Gratama JW; Sieuwerts AM; Martens JW; Foekens JA; Sleijfer S
Mol Cancer Ther; 2015 Mar; 14(3):821-7. PubMed ID: 25552367
[TBL] [Abstract][Full Text] [Related]
18. The detection of EpCAM(+) and EpCAM(-) circulating tumor cells.
de Wit S; van Dalum G; Lenferink AT; Tibbe AG; Hiltermann TJ; Groen HJ; van Rijn CJ; Terstappen LW
Sci Rep; 2015 Jul; 5():12270. PubMed ID: 26184843
[TBL] [Abstract][Full Text] [Related]
19. Circulating CEA-positive and EpCAM-negative tumor cells might be a predictive biomarker for recurrence in patients with gastric cancer.
Miki Y; Yashiro M; Kuroda K; Okuno T; Togano S; Masuda G; Kasashima H; Ohira M
Cancer Med; 2021 Jan; 10(2):521-528. PubMed ID: 33381922
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies.
Tewes M; Aktas B; Welt A; Mueller S; Hauch S; Kimmig R; Kasimir-Bauer S
Breast Cancer Res Treat; 2009 Jun; 115(3):581-90. PubMed ID: 18679793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
